TEVA - Teva Pharmaceutical ...About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $12.18 | Open | $12.22 |
| Volume | 5.82M | Market Cap | 13.707B |
| Yield | Last Dividend |
| Parkinson???s Disease Therapeutic Market... | 01/19/21 |
| Coherent Market Insights released a new market study on 2018-2026 ???Parkinson???s Disease Therapeutic Market??? with 100+ market data Tables, Pie Cha... | |
| Global Eating Disorder Market 2021: Grow... | 01/19/21 |
| Eating disorder market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is gr... | |
| Global Acromegaly Market 2021: Future Pr... | 01/18/21 |
| The Report Titled on ???Acromegaly Market Report-Development Trends, Market Size, Industry Opportunities and Competitive Landscape in 2020??? firstly ... | |
| Malaria Treatment Market Business Opport... | 01/18/21 |
| Malaria remains a notable cause of death and illness among adults and children. Plasmodium parasites are the causative reason for malaria infection. C... | |
| Business and Trading Update (Shield Ther... | 01/15/21 |
| ) Shield Therapeutics plc ("Shield" or the "Group" or the "Company") Business and trading update London, UK, 15 January 2021: Shield Therapeutics plc ... | |
| Teva Announces Launch of a Generic Versi... | 01/14/21 |
| TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and... | |
| Parkinson???s Disease Therapeutic Market... | 01/13/21 |
| Parkinson???s Disease Therapeutic Market Report evaluated the historical and current performance of the market, especially highlighting the key trends... | |
| Kare Schultz: Teva set for single-digit ... | 01/13/21 |
| Although cuts, consolidation and streamlining will continue, the Teva CEO told the JP Morgan Healthcare Conference that the company will return to rev... | |
| RBC Capital Stick to Their Hold Rating f... | 01/12/21 |
| RBC Capital Stick to Their Hold Rating for Teva Pharmaceutical Industries Limited | |
| Overactive Bladder Treatment Market Reve... | 01/12/21 |
| CMI published a business research report on ???Overactive Bladder Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecas... | |
| Teva Sets Ambitious Long-Term Environmen... | 01/12/21 |
| Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has announced long-term environmental sustainability commitments and targets to provide dire... | |
| Teva to Host Conference Call to Discuss ... | 01/08/21 |
| TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its... | |
| Global Rituximab Biosimilars Market Repo... | 01/08/21 |
| DUBLIN--(BUSINESS WIRE)--The "Rituximab Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMark... | |
| Teva to Present at the 39th Annual J.P. ... | 01/07/21 |
| TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that President & CEO K??re Schultz will p... | |
| Teva and MedinCell Announce Positive Res... | 01/07/21 |
| TEL AVIV, Israel & PARIS--(BUSINESS WIRE)--Teva Pharmaceuticals Industries Ltd. (NYSE and TASE: TEVA) and MedinCell (Euronext: MEDCL) today announced ... | |
| Simplivia Healthcare buys diagnostics co... | 01/05/21 |
| FIMI controlled Simplivia, whioch develops devices for the safe administration of hazardous drugs, operates out of the former Teva factory in Kiryat S... | |
| Parkinson's Disease Therapeutics Market ... | 01/05/21 |
| Parkinson's Disease Therapeutics Market Report 2020-2026 incorporates a complete examination of the current market. The report begins with the fundame... | |
| Teva can't protect blockbuster Copaxone ... | 01/04/21 |
| Teva Pharmaceutical Industries Ltd has lost a bid to force the U.S. Food and Drug Administration to regulate its blockbuster multiple sclerosis drug C... | |
| Contraceptives Market Outlook and Deep S... | 01/04/21 |
| Data Bridge Market Research has recently added a concise research on the Global Contraceptives Market to depict valuable insights related to significa... | |
| Oncology Biosimilars Market Climbs on Po... | 01/04/21 |
| The latest 100+ page survey report on Oncology Biosimilars Market is released by CMI covering various players of the industry selected from global geo... | |
| Global Ethical Pharmaceuticals Market 20... | 01/04/21 |
| ???Global Ethical Pharmaceuticals Market- Industry Trends and Forecast to 2027??? Worldwide Industry Size, Offer and trends analysis during Period. Et... | |
| Pfizer, GSK & Others Quietly Hike Prices... | 12/31/20 |
| Pfizer, GSK & Others Quietly Hike Prices On 100s Of Drugs With just hours to go until the new year, Reuters reports that a group of the world's larges... | |
| 2020 Ongoing Marketplace Opportunities i... | 12/30/20 |
| It is our aim to provide our readers with report for Oncology Biosimilars Market, which examines the industry during the period 2020 ??? 2026. One goa... | |
| Consumer Healthcare Market Is Booming Wo... | 12/30/20 |
| Global Consumer Healthcare Market Insights, Forecast to 2025 is latest research study released by HTF MI evaluating the market, highlighting opportuni... | |
| Global Narcolepsy Treatment Market Resea... | 12/29/20 |
| The Narcolepsy Treatment market report is a window to the industry which explains what market definition, classifications, applications, engagements a... | |
| Pharmaceutical Pfizer, AstraZeneca and A... | 12/28/20 |
| The Innovation Lab will have a budget of 10 million dollars, will be located in the Rehovot Science Park and will begin operations in 2021. The partne... | |
| Potassium Gluconate Market With Leading ... | 12/27/20 |
| Potassium gluconate is mineral drug therapy generally given in patients with lower potassium levels in their blood stream which is referred to as hypo... | |
| Global COVID-19 Infection Market Impress... | 12/18/20 |
| Data bridge market research???s following report demonstrates the CAGR values for the historic years 2019 and the base year 2018.This geographical con... | |
| Global Sleep Disorder Treatment Market D... | 12/18/20 |
| A number of research gear were used to provide a specific knowledge of this market, consisting of Porter's 5 forces evaluation and SWOT analysis. The ... | |
| IBI sees 50% upside in Teva | 12/16/20 |
| IBI analyst Steven Tepper sees a leaner and more efficient Teva returning to growth in 2021. | |
| Buy rating | 11/06/20 |
| BMO Capital maintains Market Perform rating and lowers Price Target from $13.00 to $11.00 | |
| Date | 2020-11-05 (BMO) | Est. (EPS/Rev.) | $0.58/ 4.07B |
| Actual (EPS/Rev.) | $0.58/ $3.98 B | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Trading | Trading | 99.00 % | Follow |
| Free Biotech Holdings | Scientia Equity Research | 83.00 % | Follow |
| Equity and Teens | Equity and Teens | 75.00 % | Follow |
| Swing for the fences | Gino Baldassano | 72.00 % | Subscribe |
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
